|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
THERAPEUTIC REVIEW |
From the Department of Pediatrics, LSU Health Sciences Center, Shreveport, Louisiana (Dr. Wilson, Dr. Springer) and the Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (Dr. Kearns).
This article examines the feasibility, effectiveness, and ethical constraints relevant to appropriate financial compensation of the pediatric house officer who functions as a research-subject locator (RSL). When carefully trained and supervised, the RSL can facilitate timely enrollment of research subjects in pediatric drug trials, augment the house officer training experience, and advocate for children to increase therapeutic options available for pediatric care. When monitored within the clinical trial schema, the RSL has no direct link to the study outcome and thus performs within ethical standards for subject enrollment and study participation.
Key Words: Research-subject locator pediatrics clinical trials patient recruitment
Address for reprints: John T. Wilson, MD, Section on Clinical Pharmacology, Department of Pediatrics, Children's Hospital, LSUHSC-Shreveport, P.O. Box 33932, Room B-5-243, Shreveport, LA 71130.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |